Chronic fatigue syndrome and high allostatic load: results from a population-based case-control study in Georgia.
Maloney, Elizabeth M, Boneva, Roumiana, Nater, Urs M et al. · Psychosomatic medicine · 2009 · DOI
Quick Summary
This study looked at whether people with ME/CFS have higher levels of 'allostatic load'—a measure of how much stress and wear-and-tear their bodies have accumulated over time. Researchers compared 83 people with ME/CFS, 202 people with some symptoms but not full ME/CFS, and 109 healthy controls in Georgia. They found that people with ME/CFS did have significantly higher allostatic load than healthy people, suggesting their bodies may be under greater physiological stress.
Why It Matters
This study provides biological support for the experience of ME/CFS patients by demonstrating measurable physiological dysregulation (allostatic load) associated with the disease. Understanding that ME/CFS involves cumulative physiological stress helps validate patient experiences and may inform future therapeutic approaches targeting stress response systems. The finding that this association holds independent of depression strengthens the case for ME/CFS as a distinct biological condition.
Observed Findings
Each 1-point increase in allostatic load index was associated with 26% increased odds of ME/CFS versus healthy controls (adjusted OR=1.26, 95% CI=1.00–1.59).
The association between allostatic load and ME/CFS remained significant after adjusting for depression.
Allostatic load increased in a gradient pattern across well controls, insufficient symptoms/fatigue group, and ME/CFS cases.
Among ME/CFS patients, longer fatigue duration was inversely correlated with allostatic load index (r=−0.26, p=0.047).
Compared to the insufficient symptoms/fatigue group, the allostatic load-ME/CFS association was attenuated (OR=1.10, 95% CI=0.93–1.31).
Inferred Conclusions
ME/CFS is associated with elevated cumulative physiological stress (allostatic load) beyond what is seen in healthy controls.
Allostatic load may represent a measurable biological mechanism underlying ME/CFS pathophysiology.
The allostatic load gradient across disease severity suggests it may serve as a marker of disease burden or progression.
The inverse correlation between fatigue duration and allostatic load suggests potential disease phenotypes or adaptation patterns that warrant further investigation.
Remaining Questions
What This Study Does Not Prove
This study does not establish causation—high allostatic load may result from ME/CFS rather than cause it, or both may be caused by a third factor. The cross-sectional design means we cannot determine whether allostatic load accumulates *before* ME/CFS onset or *because of* having ME/CFS. The study also does not prove that reducing allostatic load would improve ME/CFS outcomes.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:PEM Not DefinedWeak Case DefinitionSmall Sample
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Does allostatic load increase *before* ME/CFS onset (a risk factor) or *because of* ME/CFS (a consequence)?
Which specific physiological systems contributing to allostatic load are most dysregulated in ME/CFS?
What explains the inverse correlation between longer fatigue duration and higher allostatic load—do patients with longer disease duration achieve better physiological adaptation?
Could allostatic load reduction through targeted interventions improve ME/CFS symptoms and functional outcomes?